Ascribe Bio Secures $12 Million Series A Funding to Advance Natural Crop Protection Platform
2024 field trials in India confirm Ascribe Bio's Phytalix® reduces Bacterial Leaf Blight (BLB) severity by 83%, outperforming current treatments by over 20%.